» Articles » PMID: 33227028

Diagnostic Performance of Chest Computed Tomography During the Epidemic Wave of COVID-19 Varied As a Function of Time Since the Beginning of the Confinement in France

Overview
Journal PLoS One
Date 2020 Nov 23
PMID 33227028
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the diagnostic performance of the initial chest CT to diagnose COVID-19 related pneumonia in a French population of patients with respiratory symptoms according to the time from the onset of country-wide confinement to better understand what could be the role of the chest CT in the different phases of the epidemic.

Material And Method: Initial chest CT of 1064 patients with respiratory symptoms suspect of COVID-19 referred between March 18th, and May 12th 2020, were read according to a standardized procedure. The results of chest CTs were compared to the results of the RT-PCR.

Results: 546 (51%) patients were found to be positive for SARS-CoV2 at RT-PCR. The highest rate of positive RT-PCR was during the second week of confinement reaching 71.9%. After six weeks of confinement, the positive RT-PCR rate dropped significantly to 10.5% (p<0.001) and even 2.2% during the two last weeks. Overall, CT revealed patterns suggestive of COVID-19 in 603 patients (57%), whereas an alternative diagnosis was found in 246 patients (23%). CT was considered normal in 215 patients (20%) and inconclusive in 1 patient. The overall sensitivity of CT was 88%, specificity 76%, PPV 79%, and NPV 85%. At week-2, the same figures were 89%, 69%, 88% and 71% respectively and 60%, 84%, 30% and 95% respectively at week-6. At the end of confinement when the rate of positive PCR became extremely low the sensitivity, specificity, PPV and NPV of CT were 50%, 82%, 6% and 99% respectively.

Conclusion: At the peak of the epidemic, chest CT had sufficiently high sensitivity and PPV to serve as a first-line positive diagnostic tool but at the end of the epidemic wave CT is more useful to exclude COVID-19 pneumonia.

Citing Articles

Thoracic imaging tests for the diagnosis of COVID-19.

Ebrahimzadeh S, Islam N, Dawit H, Salameh J, Kazi S, Fabiano N Cochrane Database Syst Rev. 2022; 5:CD013639.

PMID: 35575286 PMC: 9109458. DOI: 10.1002/14651858.CD013639.pub5.

References
1.
Dai H, Zhang X, Xia J, Zhang T, Shang Y, Huang R . High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China. Int J Infect Dis. 2020; 95:106-112. PMC: 7136866. DOI: 10.1016/j.ijid.2020.04.003. View

2.
Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L . CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020; 296(2):E97-E104. PMC: 7233402. DOI: 10.1148/radiol.2020201473. View

3.
Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T . Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020; 80(5):e1-e6. PMC: 7102530. DOI: 10.1016/j.jinf.2020.03.004. View

4.
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W . Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020; 296(2):E32-E40. PMC: 7233399. DOI: 10.1148/radiol.2020200642. View

5.
Kim H, Hong H, Yoon S . Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology. 2020; 296(3):E145-E155. PMC: 7233409. DOI: 10.1148/radiol.2020201343. View